实用肿瘤学杂志 ›› 2009, Vol. 23 ›› Issue (2): 143-145.doi: 10.3969/j.issn.1002-3070.2009.02.012

• 论著 • 上一篇    下一篇

氩氦刀治疗恶性肿瘤细胞免疫功能变化的临床分析

杨宝亮1, 安云凤1, 徐富刚1, 张艳桥2   

  1. 1.牡丹江医学院附属红旗医院(牡丹江 157011);
    2.哈尔滨医科大学附属肿瘤医院
  • 收稿日期:2008-04-14 出版日期:2009-04-20 发布日期:2012-02-21
  • 作者简介:杨宝亮, 女, (1970-), 硕士, 从事肿瘤学研究
  • 基金资助:
    牡丹江医学院科研项目(B200802)

Clinical analysis of cellular immunity function in malignant tumor treated by cryosurgery

YAN Baoliang1, AN Yunfeng1, XU Fugang1, Zhang Yanqiao2   

  1. 1.The Affiliated Hongqi Hospital of Mudanjiang Medical College, Mudanjiang 157011;
    2.The Affiliated Tumor Hospital of Harbin Medical University, Harbin 150081
  • Received:2008-04-14 Online:2009-04-20 Published:2012-02-21

摘要: 目的探讨恶性肿瘤患者经氩氦刀治疗前后T细胞亚群的变化。方法 选取2005年6月-2006年12月的患者, 均经病理诊断为Ⅲ期或Ⅳ期的晚期恶性肿瘤, 105例患者瘤灶共计109个。病例选择标准:患者预期生存期大于3个月, 实验期间均未接受氩氦刀以外的其他治疗。氩氦刀治疗前1周及治疗后1-2周收集标本, 做T细胞亚群分析, 外周血T细胞亚群CD3+、CD4+、CD8+、CD4+/CD8+采用流式细胞术检测。结果 术后3-12个月复查CT示肿瘤明显缩小, 部分患者肿瘤消失。恶性肿瘤患者在氩氦刀治疗后外周血CD3+、CD4+、CD4+/CD8+比治疗前明显升高(P<0.05)。结论 恶性肿瘤患者经氩氦刀治疗后可以增强细胞免疫功能, 提高抗肿瘤能力。

Abstract: Objective To investigate the T cell subsets changes of patients with malignant tumors treated by Cryosurgery.Methods 109 tumors were collected from 105 patients who have been diagnosed as pathological stage Ⅲ or Ⅳ period advanced cancer and the expected survival time of patients were more than three months since June 2005 to December 2006.Samples were collected one week before and after 1-2 weeks treatment with Cryosurgery.T-cell subsets of peripheral blood CD3+, CD4+, CD8+, CD4+/CD8+were analyzed using flow cytometry without other treatment.Results After 3-12 months of Cryosurgery treatments the tumor was getting reduced significantly on CT and tumor was found disappered in some patients's.It was also found that the peripheral blood CD3+, CD4+, CD4+/CD8+from malignant tumors patients treated with Cryosurgery were significant increased(P<0.05)compared to that of before treatment.Conclusion Treatment of Cryosurgery can enhance the cellular immune functions and improve the anti-tumor capacity of patients with malignant tumors.

中图分类号: